China reduces by some medicines prices Lighten the burden nearly ten billion yuan for people every year

China reduces by some medicines prices Lighten the burden nearly ten billion yuan for people every year
Cable of March 7 of Beijing of China News Service (reporter Yu Lan) China determines to reduce the supreme retail prices of some antibiotic and circulatory system medicines from March 28, it is estimated that can lighten by nearly 10 billion yuan of people's burden every year. These medicines are used mainly for treating and is infected with and cardiovascular vessel, involve 162 varieties together, nearly 1300 dosage form specifications. Than stipulate price reduce 21% on average while being current price adjust. China is deepening the system reform of the health care, in order to relieve the difficulty and high cost of getting medical treatment questions of people. Reduce one of the important contents that the price of medicines is the reform. It is in extensive range that antibiotic and circulatory system medicines are used in China. Reduce the price of these medicines, will lighten patient's financial burden notably. The relevant officers of national development and reform committee say on the 7th, the national development and reform committee is on the basis that investigated at cost and price, through pricing procedures such as the expert appraisal, listening to the opinion concerned,etc., have confirmed the adjustment scheme of prices finally. It is introduced, this price adjustment has considered factors such as the medicines production cost and real trade price of market,etc. synthetically, and distinguish different situations, stress the key points: --Costly medicines strengthen, make a reduction and the intersection of expenses and low medicines make a reduction or not make a reduction little to day to day. The official side hopes to guarantee the production supply of relatively low medicines of price while lightening patient's burden. --The range that innovative medicines control making a reduction appropriately to patent,etc., in order to encourage the research and development innovation of medicines. --Medicines, have further narrowed with the price differential between unified price medicines to already pricing alone, in order to safeguard the fair competitive environment of the market. It is a measure that governments of various countries generally take to implement essential supervision to the price of medicines. It's time to be responsible for being called, the national development and reform committee will also reduce the medicines price in the other government issused price range by stages and in groups in the future.

|